Ads
related to: genomic testing companiesalphaid.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. [1] It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, [2] to generate reports relating to the customer's ancestry and genetic ...
McDonnell Genome Institute (Washington University in St. Louis) New Mexico. National Center for Genome Resources; New York. Cold Spring Harbor Laboratory; Icahn Institute for Genomics and Multiscale Biology (Icahn School of Medicine) New York Genome Center; International Society for Transgenic Technologies; North Carolina. Metabolon, Inc; South ...
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States.Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease.
Helix uses NGS to sequence a proprietary assay called Exome+, a version of Exome sequencing which according to the company provides 100 times more data than was previously available. [9] Exome+ includes all 22,000 protein-coding genes as well as additional regions known to be of interest. [ 10 ]
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows ...
The test is a dry anterior nasal swab, approved for use either in an on-site or at-home setting without the need for a healthcare provider to monitor sample collection, which eases the burden on the healthcare system and reduces testing costs. [20] The company has received an FDA EUA for the testing assay, which is a nucleic acid amplification ...